Diabetes Care:糖尿病患者脑功能连接异常与认知障碍有关

2014-04-09 佚名 丁香园

胰岛素抵抗是2型糖尿病的主要特征,并参与了阿尔茨海默病的发生和发展。然而,2型糖尿病患者发生认知功能障碍的确切机制仍不清楚。为此,来自东南大学附属中大医院的滕皋军教授及其团队进行了一项研究,探讨2型糖尿病患者静息状态下脑功能连接异常与胰岛素抵抗之间的关系。该研究结果在线发表在2014年03月21日的Diabetes Care杂志上。 该研究为一项前瞻性研究,受试者为30例2型糖尿病患者和31例良

胰岛素抵抗是2型糖尿病的主要特征,并参与了阿尔茨海默病的发生和发展。然而,2型糖尿病患者发生认知功能障碍的确切机制仍不清楚。为此,来自东南大学附属中大医院的滕皋军教授及其团队进行了一项研究,探讨2型糖尿病患者静息状态下脑功能连接异常与胰岛素抵抗之间的关系。该研究结果在线发表在2014年03月21日的Diabetes Care杂志上。

该研究为一项前瞻性研究,受试者为30例2型糖尿病患者和31例良好匹配的健康志愿者。使用静息状态下脑功能连接分析检查后扣带皮层(PCC)与整个脑区之间的联系。使用稳态模型评估的胰岛素抵抗指数(HOMA-IR)评估功能连接强度与胰岛素抵抗之间可能的关系。

研究结果表明,与健康对照者相比,2型糖尿病患者大脑某些特定区域内,包括右侧颞中回(MTG),左侧舌回,左侧枕中回和左侧中央前回,PCC功能连接强度显著下降;同时,在左侧小脑后叶,右侧额上回和右侧额中回发现PCC功能连接强度增加。2型糖尿病患者PCC-MTG功能连接情况与HOMA-IR呈显著负相关。

该研究提示,2型糖尿病患者大脑某些特定区域内PCC功能连接异常与胰岛素抵抗有关。静息状态PCC-MTG功能连接紊乱可能在2型糖尿病认知功能障碍中发挥关键作用。

原始出处:


Chen YC1, Jiao Y, Cui Y, Shang SA, Ding J, Feng Y, Song W, Ju SH, Teng GJ.Aberrant Brain Functional Connectivity Related to Insulin Resistance in Type 2 Diabetes: A Resting-State fMRI Study.Diabetes Care. 2014 Mar 21. 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1636842, encodeId=5ac41636842dc, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Aug 15 04:14:00 CST 2014, time=2014-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759425, encodeId=6f7a1e59425e9, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Mar 03 07:14:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901196, encodeId=ae5f190119677, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Apr 17 15:14:00 CST 2014, time=2014-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442398, encodeId=ad8d144239810, content=<a href='/topic/show?id=dfae84e3003' target=_blank style='color:#2F92EE;'>#脑功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84730, encryptionId=dfae84e3003, topicName=脑功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00224929300, createdName=ms1467340776200723, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445757, encodeId=03f51445e5773, content=<a href='/topic/show?id=a343329413c' target=_blank style='color:#2F92EE;'>#功能连接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32941, encryptionId=a343329413c, topicName=功能连接)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJciayulicXZn6VO5hXfUv98oceXTHpMayS6T4PrSPsgsN6Jt2kCyAo9tAQwf1jCiaw4y8lxZFBA5nJg/132, createdBy=5ddb5182578, createdName=showtest, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473779, encodeId=e0ab14e377990, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1636842, encodeId=5ac41636842dc, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Aug 15 04:14:00 CST 2014, time=2014-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759425, encodeId=6f7a1e59425e9, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Mar 03 07:14:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901196, encodeId=ae5f190119677, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Apr 17 15:14:00 CST 2014, time=2014-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442398, encodeId=ad8d144239810, content=<a href='/topic/show?id=dfae84e3003' target=_blank style='color:#2F92EE;'>#脑功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84730, encryptionId=dfae84e3003, topicName=脑功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00224929300, createdName=ms1467340776200723, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445757, encodeId=03f51445e5773, content=<a href='/topic/show?id=a343329413c' target=_blank style='color:#2F92EE;'>#功能连接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32941, encryptionId=a343329413c, topicName=功能连接)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJciayulicXZn6VO5hXfUv98oceXTHpMayS6T4PrSPsgsN6Jt2kCyAo9tAQwf1jCiaw4y8lxZFBA5nJg/132, createdBy=5ddb5182578, createdName=showtest, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473779, encodeId=e0ab14e377990, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=)]
    2015-03-03 智智灵药
  3. [GetPortalCommentsPageByObjectIdResponse(id=1636842, encodeId=5ac41636842dc, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Aug 15 04:14:00 CST 2014, time=2014-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759425, encodeId=6f7a1e59425e9, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Mar 03 07:14:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901196, encodeId=ae5f190119677, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Apr 17 15:14:00 CST 2014, time=2014-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442398, encodeId=ad8d144239810, content=<a href='/topic/show?id=dfae84e3003' target=_blank style='color:#2F92EE;'>#脑功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84730, encryptionId=dfae84e3003, topicName=脑功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00224929300, createdName=ms1467340776200723, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445757, encodeId=03f51445e5773, content=<a href='/topic/show?id=a343329413c' target=_blank style='color:#2F92EE;'>#功能连接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32941, encryptionId=a343329413c, topicName=功能连接)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJciayulicXZn6VO5hXfUv98oceXTHpMayS6T4PrSPsgsN6Jt2kCyAo9tAQwf1jCiaw4y8lxZFBA5nJg/132, createdBy=5ddb5182578, createdName=showtest, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473779, encodeId=e0ab14e377990, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1636842, encodeId=5ac41636842dc, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Aug 15 04:14:00 CST 2014, time=2014-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759425, encodeId=6f7a1e59425e9, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Mar 03 07:14:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901196, encodeId=ae5f190119677, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Apr 17 15:14:00 CST 2014, time=2014-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442398, encodeId=ad8d144239810, content=<a href='/topic/show?id=dfae84e3003' target=_blank style='color:#2F92EE;'>#脑功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84730, encryptionId=dfae84e3003, topicName=脑功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00224929300, createdName=ms1467340776200723, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445757, encodeId=03f51445e5773, content=<a href='/topic/show?id=a343329413c' target=_blank style='color:#2F92EE;'>#功能连接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32941, encryptionId=a343329413c, topicName=功能连接)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJciayulicXZn6VO5hXfUv98oceXTHpMayS6T4PrSPsgsN6Jt2kCyAo9tAQwf1jCiaw4y8lxZFBA5nJg/132, createdBy=5ddb5182578, createdName=showtest, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473779, encodeId=e0ab14e377990, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1636842, encodeId=5ac41636842dc, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Aug 15 04:14:00 CST 2014, time=2014-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759425, encodeId=6f7a1e59425e9, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Mar 03 07:14:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901196, encodeId=ae5f190119677, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Apr 17 15:14:00 CST 2014, time=2014-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442398, encodeId=ad8d144239810, content=<a href='/topic/show?id=dfae84e3003' target=_blank style='color:#2F92EE;'>#脑功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84730, encryptionId=dfae84e3003, topicName=脑功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00224929300, createdName=ms1467340776200723, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445757, encodeId=03f51445e5773, content=<a href='/topic/show?id=a343329413c' target=_blank style='color:#2F92EE;'>#功能连接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32941, encryptionId=a343329413c, topicName=功能连接)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJciayulicXZn6VO5hXfUv98oceXTHpMayS6T4PrSPsgsN6Jt2kCyAo9tAQwf1jCiaw4y8lxZFBA5nJg/132, createdBy=5ddb5182578, createdName=showtest, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473779, encodeId=e0ab14e377990, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1636842, encodeId=5ac41636842dc, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Fri Aug 15 04:14:00 CST 2014, time=2014-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759425, encodeId=6f7a1e59425e9, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=智智灵药, createdTime=Tue Mar 03 07:14:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1901196, encodeId=ae5f190119677, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Thu Apr 17 15:14:00 CST 2014, time=2014-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442398, encodeId=ad8d144239810, content=<a href='/topic/show?id=dfae84e3003' target=_blank style='color:#2F92EE;'>#脑功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84730, encryptionId=dfae84e3003, topicName=脑功能)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00224929300, createdName=ms1467340776200723, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445757, encodeId=03f51445e5773, content=<a href='/topic/show?id=a343329413c' target=_blank style='color:#2F92EE;'>#功能连接#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32941, encryptionId=a343329413c, topicName=功能连接)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJciayulicXZn6VO5hXfUv98oceXTHpMayS6T4PrSPsgsN6Jt2kCyAo9tAQwf1jCiaw4y8lxZFBA5nJg/132, createdBy=5ddb5182578, createdName=showtest, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473779, encodeId=e0ab14e377990, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Apr 11 00:14:00 CST 2014, time=2014-04-11, status=1, ipAttribution=)]

相关资讯

CJASN:严重抑郁或增糖尿病患者肾衰风险

     美国学者 Bessie A. Young研究发现,严重抑郁症状与糖尿病患者终末期肾脏病(ESRD)发生风险较高相关。论文3月27日在线发表于《美国肾脏病学会临床杂志》(Clin J Am Soc Nephrol)。     该研究共纳入3886例糖尿病门诊患者,并收集抑郁症状和糖尿病自我护理模式等资料,评估

JCEM:天芪降糖胶囊减慢糖尿病患者糖耐量减退

最近一项多中心临床试验表明,中药复方天芪降糖胶囊可能具有抑制糖耐量异常的作用。在这项研究中,共420例糖耐量受损(impaired glucose tolerance,IGT)患者被随机分为天芪降糖胶囊组和安慰剂组,共治疗12个月。每3个月进行口服糖耐量测试,同时,所有患者均受到相同的生活方式教育。主要终点为最终IGT转换为II型糖尿病的比例。研究发现,在整个12个月试验中,天芪降糖胶囊湘鄂赣18

纪立农:糖尿病相关卒中风险的性别差异

2014年3月7日纪立农教授在The Lancet 上发布了一则评论,就女性糖尿病患者的糖尿病相关卒中风险显著高于男性患者进行了讨论。 在普通人群中,卒中在男性中比在女性中更为常见。而且,男性的年龄特异性卒中发生率也高于女性,但年龄35~44岁和大于85岁的女性应除外,在这两个年龄段中,女性的年龄特异性卒中发病率略高于男性。妊娠和口服避孕药的使用等因素可能是导致女性35~44岁期间卒中风险增

JAAOS:糖尿病骨骼肌肉表现和骨科围手术期处置

糖尿病是未经控制的高血糖状态。尽管目前对糖尿病的病理生理有了足够的了解,并且已经开发出了控制血糖较有针对性的药物,但该病的发生率及由该病引发的严重后果后遗症的人群仍在持续上升。糖尿病导致的神经,血管,免疫系统等并发损伤使得这类患者的骨骼肌肉结果较正常更易受损。 糖尿病患者的足部损伤是目前为止最为常见的骨科损伤类型,除此之外,上肢,脊柱,肌肉等也均较正常患者更易出现问题。骨科医生目前面

Lancet Diab & Endo:大庆糖尿病预防研究23年随访结果公布

4月3日,北京中日友好医院李光伟教授等在《柳叶刀·糖尿病与内分泌学》(The Lancet Diabetes & Endocrinology)杂志发表了“大庆糖尿病预防研究”23年随访结果:中国糖耐量受损人群进行生活方式干预6年,随访23年显示心血管病死亡和全因死亡显著降低。这是全球首项证明生活方式干预可降低糖尿病高危人群心血管病死亡和全因死亡的高质量随机对照试验。 1986年,